Silvia N. Calderon

995 citations

31 papers · 769 indexed · h-index 14

Cellular and Molecular Neuroscience top 5%
- Neuropeptides and Animal Physiology 16
- Neuroscience and Neuropharmacology Research 2
Toxicology top 5%
- Forensic Toxicology and Drug Analysis 3
Molecular Biology
- Receptor Mechanisms and Signaling 14
- Pharmacological Receptor Mechanisms and Effects 12
- Chemical Synthesis and Analysis 4
Behavioral Neuroscience
Physiology
Public Health, Environmental and Occupational Health
- Opioid Use Disorder Treatment 4
Anesthesiology and Pain Medicine
- Pain Management and Opioid Use 2

Co-authors: Richard B. Rothman Peg Davis Edward J. Bilsky Kenner C. Rice Robert W. McNutt Frank Porreca Victor J. Hruby Michael Klein
Cited by: Cellular and Molecular Neuroscience Toxicology Molecular Biology
Journals: Journal of Medicinal Chemistry (6 papers)Journal of Pharmacology and Experimental Therapeutics (5 papers)Regulatory Peptides (4 papers)
Partner nations: United States Austria China

In The Last Decade

Silvia N. Calderon

30 papers receiving 731 citations

Peers

Countries citing papers authored by Silvia N. Calderon

Since Specialization

Citations

This map shows the geographic impact of Silvia N. Calderon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia N. Calderon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia N. Calderon more than expected).

Fields of papers citing papers by Silvia N. Calderon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia N. Calderon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia N. Calderon. The network helps show where Silvia N. Calderon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Silvia N. Calderon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Silvia N. Calderon Line = papers co-authored together Silvia N. Calderon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Considerations in assessing the abuse potential of psychedelics during drug development Neuropharmacology ·Silvia N. Calderon,Katherine R. Bonson,Chad J. Reissig,Elsbeth Schaap,Fangpeng Lu,康之木村	2022	10
2	Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidance EClinicalMedicine ·Liang Zhao,Zhichuan Li,Lanyan Fang,Myong‐Jin Kim,Srikanth C. Nallani,Chandrahas Sahajwalla,Silvia N. Calderon,J. H. Park,Kairui Feng,Issam Zineh,Robert Lionberger	2021	3
3	A regulatory perspective on the evaluation of hallucinogen drugs for human use Neuropharmacology ·Silvia N. Calderon,Joshua C. Hunt,Michael Klein	2017	14
4	Risk based in vitro performance assessment of extended release abuse deterrent formulations International Journal of Pharmaceutics ·Xiaoming Xu,Abhay Gupta,Rahul Bhargav Tallada,Silvia N. Calderon,Mansoor A. Khan	2016	24
5	A regulatory perspective on the abuse potential evaluation of novel stimulant drugs in the United States Neuropharmacology ·Silvia N. Calderon,Michael Klein	2014	15
6	Nonpeptidic Delta (δ) Opioid Agonists and Antagonists of the Diarylmethylpiperazine Class: What Have We Learned? Topics in current chemistry ·Silvia N. Calderon	2010	4
7	Assessment of SNC 80 and Naltrindole Within a Conditioned Taste Aversion Design Pharmacology Biochemistry and Behavior ·Steve Vaughn,Burhanuddin Malik,Víctor Calvo Betancur,Dewitte Griet,Silvia N. Calderon,Kenner C. Rice,Anthony L. Riley	2000	12
8	Abuse Liability Assessment of Neuroprotectants Annals of the New York Academy of Sciences ·Michael Klein,Silvia N. Calderon,MN Patil	1999	20
9	Opioid peptide receptor studies. 9. Identification of a novel non-μ- non-δ-like opioid peptide binding site in rat brain Peptides ·Qing Zhe Ni,Heng Xu,John S. Partilla,Kenner C. Rice,Dorota Matecka,Silvia N. Calderon,Frank Porreca,Josephine Lai,Helmut Schmidhammer,W.C. Keettel,Richard B. Rothman	1998	6
10	Probes for Narcotic Receptor-Mediated Phenomena. 25. Synthesis and Evaluation ofN-Alkyl-Substituted (α-Piperazinylbenzyl)benzamides as Novel, Highly Selective δ Opioid Receptor Agonists Journal of Medicinal Chemistry ·Walther Prokosch,Xiaoyan Zhang,Koichi J. Homma,Kenner C. Rice,Silvia N. Calderon,Richard B. Rothman,Henry I. Yamamura,Peg Davis,J.L. Flippen-Anderson,Heng Xu,K. Becketts,Ryan Xiao,Frank Porreca	1997	12
11	Probes for Narcotic Receptor Mediated Phenomena. 23. Synthesis, Opioid Receptor Binding, and Bioassay of the Highly Selective δ Agonist (+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and Related Novel Nonpeptide δ Opioid Receptor Ligands Journal of Medicinal Chemistry ·Silvia N. Calderon,Kenner C. Rice,Richard B. Rothman,Frank Porreca,J.L. Flippen-Anderson,Hiroshi Kayakiri,Heng Xu,K. Becketts,ورود نعمه موسى,Edward J. Bilsky,Peg Davis,Róbert Horváth	1997	69
12	Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. Journal of Pharmacology and Experimental Therapeutics ·Ewa Malatyńska,Yu Wang,Richard J. Knapp,Sue Waite,Silvia N. Calderon,Kenner C. Rice,Victor J. Hruby,Henry I. Yamamura,William R. Roeske	1996	38
13	Rapid in vivo metabolism of a methylether derivative of (+/-)-BW373U86: the metabolic fate of [3H]SNC121 in rats. Journal of Pharmacology and Experimental Therapeutics ·John A. Schetz,Silvia N. Calderon,Craig M. Bertha,Kenner C. Rice,Frank Porreca	1996	12
14	Probes for narcotic receptor mediated phenomena 22. (1) synthesis and characterization of optically pure [3H](+)-4-[(αR)-α-((2S, 5R)-4-propyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide, [3H]SNC 121, a novel high affinity and select Journal of Labelled Compounds and Radiopharmaceuticals ·Silvia N. Calderon,Craig M. Bertha,J. Silvio Gutkind,Heng Xu,John S. Partilla,Richard B. Rothman,Kenner C. Rice	1996	0
15	SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. Journal of Pharmacology and Experimental Therapeutics ·Edward J. Bilsky,Silvia N. Calderon,徐冬,Robert N. Bernstein,Peg Davis,Victor J. Hruby,Robert W. McNutt,Richard B. Rothman,Kenner C. Rice,Frank Porreca	1995	163
16	Novel 1-Phenylcycloalkanecarboxylic Acid Derivatives Are Potent and Selective .sigma.1 Ligands Journal of Medicinal Chemistry ·Silvia N. Calderon,Sari Izenwasser,Rehab Abd El-Moneim Abou Shaheen,J. Silvio Gutkind,Mariena V. Mattson,Tsung-Ping Su,Amy Hauck Newman	1994	20
17	Probes for Narcotic Receptor Mediated Phenomena. 19. Synthesis of (+)-4-[(.alpha.R)-.alpha.-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC 80): A Highly Selective, Nonpeptide .delta. Opioid Receptor Agonist Journal of Medicinal Chemistry ·Silvia N. Calderon,Richard B. Rothman,Frank Porreca,JUDITH L. FLIPPEN‐ANDERSON,Robert W. McNutt,Heng Xu,ورود نعمه موسى,Edward J. Bilsky,Peg Davis,Kenner C. Rice	1994	172
18	Characterization of enantiomers of (±)BW373U86 and related compounds: Highly selective non-peptidic delta opioid agonists Regulatory Peptides ·Edward J. Bilsky,Robert N. Bernstein,Peg Davis,Silvia N. Calderon,Kenner C. Rice,Richard B. Rothman,Frank Porreca	1994	1
19	BW373U86, its enantiomers, and related compounds: Interactions of non-peptide delta agonists at multiple binding sites in rat brain Regulatory Peptides ·Earl Klee,H. Eric Xu,Silvia N. Calderon,ورود نعمه موسى,Kenner C. Rice,Frank Porreca,Richard B. Rothman	1994	1
20	Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents Journal of Medicinal Chemistry ·Silvia N. Calderon,Amy Hauck Newman,Frank C. Tortella	1991	6

About Silvia N. Calderon

Silvia N. Calderon is a scholar working on Cellular and Molecular Neuroscience, Toxicology, Anesthesiology and Pain Medicine, Pharmaceutical Science and Molecular Biology, having authored 31 papers that have together received 769 indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (16 papers), Receptor Mechanisms and Signaling (14 papers), Pharmacological Receptor Mechanisms and Effects (12 papers), Chemical Synthesis and Analysis (4 papers), Opioid Use Disorder Treatment (4 papers), Forensic Toxicology and Drug Analysis (3 papers), Pain Management and Opioid Use (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (553 citations), Toxicology (43 citations), Molecular Biology (485 citations), Behavioral Neuroscience (22 citations) and Physiology (153 citations). Silvia N. Calderon has collaborated with scholars based in United States, Austria and China. Frequent co-authors include Richard B. Rothman, Peg Davis, Edward J. Bilsky, Kenner C. Rice, Robert W. McNutt, Frank Porreca, Victor J. Hruby, Michael Klein, Heng Xu and Frank Porreca. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Regulatory Peptides, Neuropharmacology and Pain Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact